PFE stock

Pfizer Inc (PFE) support and resistance · P/E 20, rev $62.58B

Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.

This page maps Pfizer Inc (PFE) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.

PFE currently screens at market cap $147.73B and trailing P/E 19.8. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new PFE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the PFE quote page for the session range and the stock page for the full model.

Not investment advice.

Full PFE analysis